GLP-1 medicines were first made to help with diabetes and weight loss, but they might also have some benefits for people with Crohns disease, says Raseen Tariq, MD, a gastroenterologist and an assistant professor of medicine in the division of gastroenterology, hepatology, and nutrition at Virginia Commonwealth Universitys school of medicine in Richmond
It added: "Anyone who suspects they are having a side effect from this medicine should talk to their doctor, pharmacist or nurse and report it directly to the MHRA Yellow Card scheme, either through the website or by searching the Google Play or Apple App stores for MHRA Yellow Card." Will the pills replace weight loss jabs
(5) Findings from the Corbion surveys bear that out
The starting dose of Wegovy is 0.25 mg
A prescriber may consider: BMI and weight-related health risk previous weight-management attempts existing medical conditions current medicines pregnancy plans gastrointestinal health history of pancreatitis or gallbladder problems kidney and liver function diabetes treatment eating-disorder history ability to attend monitoring and follow-up NHS access is more restricted than general private eligibility